Tema Oncology ETF
CANC
NASDAQ
| Weiss Ratings | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Reward Grade | U | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Valuation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $42.10 | |||
| Company Info | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Tema ETFs | |||
| Manager/Tenure (Years) | Yuri Khodjamirian (3), Maurits Pot (3), David Song (3), 2 others | |||
| Website | http://https://temaetfs.com/ | |||
| Phone Number | 313-434-4391 | |||
| Fund Information | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Tema Oncology ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Aug 14, 2023 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.05% | |||
| Dividend | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.80% | |||
| Asset Allocation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.58% | |||
| Stock | 99.42% | |||
| U.S. Stock | 85.42% | |||
| Non-U.S. Stock | 14.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.61% | |||
| 30-Day Total Return | 2.56% | |||
| 60-Day Total Return | -5.13% | |||
| 90-Day Total Return | 1.47% | |||
| Year to Date Total Return | 21.37% | |||
| 1-Year Total Return | 37.47% | |||
| 2-Year Total Return | 56.13% | |||
| 3-Year Total Return | 89.75% | |||
| 5-Year Total Return | -- | |||
| Price | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $41.67 | |||
| 1-Month Low Price | $39.26 | |||
| 1-Month High Price | $42.60 | |||
| 52-Week Low Price | $30.44 | |||
| 52-Week Low Price (Date) | Nov 04, 2025 | |||
| 52-Week High Price | $45.24 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| NAV | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $39.24 | |||
| 1-Month High NAV | $42.54 | |||
| 52-Week Low NAV | $30.30 | |||
| 52-Week Low NAV (Date) | Nov 04, 2025 | |||
| 52-Week High NAV | $45.14 | |||
| 52-Week High Price (Date) | Aug 25, 2026 | |||
| Beta / Standard Deviation | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.64 | |||
| Standard Deviation | 19.48 | |||
| Balance Sheet | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 208.60M | |||
| Operating Ratios | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.75% | |||
| Turnover Ratio | 68.00% | |||
| Performance | CANC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 50.91% | |||
| Last Bear Market Total Return | -- | |||